Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis
Brigham and Women's Hospital
Brigham and Women's Hospital
University of Texas Southwestern Medical Center
Columbia University
Icahn School of Medicine at Mount Sinai
University of Tennessee Graduate School of Medicine
Boston Medical Center
University of Athens
University College, London
Boston Medical Center
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
University of Tennessee
Asan Medical Center
M.D. Anderson Cancer Center
Nantes University Hospital
Fred Hutchinson Cancer Center